Salete Conde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Salete Conde has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Acary Souza Bulle Oliveira
Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo SP, Brazil
1 shared publication - Alcione Aparecida Vieira de Souza Moscardi
Department of Preventive Medicine, Federal University of São Paulo, São Paulo 01000-000, Brazil
1 shared publication - Amanda Orasmo Simcsik
Rehabilitation Sciences, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo 01246-903, Brazil
1 shared publication - Chiara Rinaldi
Neurology Unit, Santo Stefano Hospital, 59100 Prato, Italy
1 shared publication - Claudete Munhoz Teixeira
Division of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo 01000-000, Brazil
1 shared publication - Jeyce Adrielly André Nogueira
Division of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, Sao Paulo 04021-001, Brazil
1 shared publication
Latest Publications
- Open Access
- 26 October 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (11) , 1536
Improving Strength and Fatigue Resistance in Post-Polio Syndrome Individuals with REAC Neurobiological Treatments
Post-Polio Syndrome (PPS) is a chronic condition characterized by the emergence of new symptoms and functional decline in individuals who previously had polio. Despite advances in medical understanding, management of PPS remains challenging. This study aimed to evaluate the use of neurobiological modulation treatments using Radio Electric Asymmetric Conveyer (REAC) technology on fatigue and muscle strength. An open-label study was conducted with 17 patients submitted to four neuromodulation protocols: Neuro Postural Optimization (NPO), Neuro Psycho Physical Optimization (NPPO), Neuro Psycho Physical Optimization—Cervico Brachial (NPPO-CB), and Neuromuscular Optimization (NMO). The Time Up and Go (TUG) test, Handgrip Strength Test, and Revised Piper Fatigue Scale (RPFS) were used to assess participants’ fatigue and muscle strength, being applied at the beginning and end of each protocol. The results obtained from the improvement in strength, physical endurance, and particularly the RPFS behavioral dimension, affective dimension, and psychological sensory dimension, through the utilization of REAC neurobiological modulation treatments, highlight this correlation. These results suggest that these treatments could be considered as a potential therapeutic approach for PPS.
- 26 October 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (11) , 1536
Open AccessImproving Strength and Fatigue Resistance in Post-Polio Syndrome Individuals with REAC Neurobiological Treatments
Post-Polio Syndrome (PPS) is a chronic condition characterized by the emergence of new symptoms and functional decline in individuals who previously had polio. Despite advances in medical understanding, management of PPS remains challenging. This study aimed to evaluate the use of neurobiological modulation treatments using Radio Electric Asymmetric Conveyer (REAC) technology on fatigue and muscle strength. An open-label study was conducted with 17 patients submitted to four neuromodulation protocols: Neuro Postural Optimization (NPO), Neuro Psycho Physical Optimization (NPPO), Neuro Psycho Physical Optimization—Cervico Brachial (NPPO-CB), and Neuromuscular Optimization (NMO). The Time Up and Go (TUG) test, Handgrip Strength Test, and Revised Piper Fatigue Scale (RPFS) were used to assess participants’ fatigue and muscle strength, being applied at the beginning and end of each protocol. The results obtained from the improvement in strength, physical endurance, and particularly the RPFS behavioral dimension, affective dimension, and psychological sensory dimension, through the utilization of REAC neurobiological modulation treatments, highlight this correlation. These results suggest that these treatments could be considered as a potential therapeutic approach for PPS.